Ngenla 24 mg/ 1.2 ml

Ngenla 24 mg/ 1.2 ml is a medicine authorised by Swissmedic under authorisation number 68265. The authorisation holder is Pfizer AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 September 2022 and the authorisation is limited until 08 September 2027. ATC code H01AC08 places the medicine in the group Pituitary and hypothalamic hormones and analogues.

  • Dispensing category A
  • Authorisation number 68265
  • ATC H01AC08
  • Biotechnological medicines
Authorisation data
Authorisation number68265
NameNgenla 24 mg/ 1.2 ml
Full nameNgenla 24 mg/ 1.2 ml, Injektionslösung im Fertigpen
Authorisation holderPfizer AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeH01AC08
First authorisation09 September 2022
Authorisation validity08 September 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Ngenla 24 mg/ 1.2 ml, Injektionslösung im FertigpenA09 September 2022
2Ngenla 60 mg/ 1.2 ml, Injektionslösung im FertigpenA09 September 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11.2mlH01AC0807.03.1.A
21.2mlH01AC0807.03.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Ngenla 24 mg/ 1.2 ml authorised in Switzerland?

Yes. Ngenla 24 mg/ 1.2 ml is authorised by Swissmedic under authorisation number 68265, data as of 01 September 2026. The authorisation is limited until 08 September 2027.

Which dispensing category does Ngenla 24 mg/ 1.2 ml have?

Ngenla 24 mg/ 1.2 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ngenla 24 mg/ 1.2 ml?

The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com